Literature DB >> 25279503

Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen.

Brandie N Radde1, Margarita M Ivanova1, Huy Xuan Mai1, Joshua K Salabei2, Bradford G Hill2, Carolyn M Klinge1.   

Abstract

Oestrogen receptor α (ERα+) breast tumours rely on mitochondria (mt) to generate ATP. The goal of the present study was to determine how oestradiol (E2) and 4-hydroxytamoxifen (4-OHT) affect cellular bioenergetic function in MCF-7 and T47D ERα+ breast cancer cells in serum-replete compared with dextran-coated charcoal (DCC)-stripped foetal bovine serum (FBS)-containing medium ('serum-starved'). Serum-starvation reduced oxygen consumption rate (OCR), extracellular acidification rate (ECAR), ATP-linked OCR and maximum mt capacity, reflecting lower ATP demand and mt respiration. Cellular respiratory stateapparent was unchanged by serum deprivation. 4-OHT reduced OCR independent of serum status. Despite having a higher mt DNA/nuclear DNA ratio than MCF-7 cells, T47D cells have a lower OCR and ATP levels and higher proton leak. T47D express higher nuclear respiratory factor-1 (NRF-1) and NRF-1-regulated, nuclear-encoded mitochondrial transcription factor TFAM and cytochrome c, but lower levels of cytochrome c oxidase, subunit IV, isoform 1 (COX4, COX4I1). Mitochondrial reserve capacity, reflecting tolerance to cellular stress, was higher in serum-starved T47D cells and was increased by 4-OHT, but was decreased by 4-OHT in MCF-7 cells. These data demonstrate critical differences in cellular energetics and responses to 4-OHT in these two ERα+ cell lines, likely reflecting cancer cell avoidance of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25279503     DOI: 10.1042/BJ20131608

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

Review 1.  Estrogens regulate life and death in mitochondria.

Authors:  Carolyn M Klinge
Journal:  J Bioenerg Biomembr       Date:  2017-08       Impact factor: 2.945

2.  Mitochondrial respiratory defects promote the Warburg effect and cancer progression.

Authors:  Satish Srinivasan; Manti Guha; Narayan G Avadhani
Journal:  Mol Cell Oncol       Date:  2015-12-10

3.  TXNIP Links Anticipatory Unfolded Protein Response to Estrogen Reprogramming Glucose Metabolism in Breast Cancer Cells.

Authors:  Yuanzhong Wang; Shiuan Chen
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 5.051

4.  Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.

Authors:  Frances E Lennon; Gianguido C Cianci; Rajani Kanteti; Jacob J Riehm; Qudsia Arif; Valeriy A Poroyko; Eitan Lupovitch; Wickii Vigneswaran; Aliya Husain; Phetcharat Chen; James K Liao; Martin Sattler; Hedy L Kindler; Ravi Salgia
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

5.  The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells.

Authors:  Penn Muluhngwi; Negin Alizadeh-Rad; Stephany L Vittitow; Ted S Kalbfleisch; Carolyn M Klinge
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

6.  Integration of flux measurements to resolve changes in anabolic and catabolic metabolism in cardiac myocytes.

Authors:  Andrew A Gibb; Pawel K Lorkiewicz; Yu-Ting Zheng; Xiang Zhang; Aruni Bhatnagar; Steven P Jones; Bradford G Hill
Journal:  Biochem J       Date:  2017-08-07       Impact factor: 3.857

Review 7.  Estrogenic control of mitochondrial function.

Authors:  Carolyn M Klinge
Journal:  Redox Biol       Date:  2020-01-23       Impact factor: 11.799

8.  Anticancer potential of some imidazole and fused imidazole derivatives: exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition.

Authors:  Sourav Kalra; Gaurav Joshi; Manvendra Kumar; Sahil Arora; Harsimrat Kaur; Sandeep Singh; Anjana Munshi; Raj Kumar
Journal:  RSC Med Chem       Date:  2020-07-08

9.  BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma.

Authors:  Fen Liu; Chen Chen Jiang; Xu Guang Yan; Hsin-Yi Tseng; Chun Yan Wang; Yuan Yuan Zhang; Hamed Yari; Ting La; Margaret Farrelly; Su Tang Guo; Rick F Thorne; Lei Jin; Qi Wang; Xu Dong Zhang
Journal:  Oncotarget       Date:  2017-05-09

10.  MiR-23a modulates X-linked inhibitor of apoptosis-mediated autophagy in human luminal breast cancer cell lines.

Authors:  Ping Chen; Yin-Huan He; Xing Huang; Si-Qi Tao; Xiao-Nan Wang; Hong Yan; Ke-Shuo Ding; Peter E Lobie; Wen-Yong Wu; Zheng-Sheng Wu
Journal:  Oncotarget       Date:  2017-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.